Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial E Pose, L Napoleone, A Amin, D Campion, C Jimenez, S Piano, O Roux, ... The Lancet Gastroenterology & Hepatology 5 (1), 31-41, 2020 | 121 | 2020 |
Epidemiology, Pathophysiology, and Management of Hepatorenal Syndrome AD Ahmed Adel Amin, MD, Eman Ibrahim Alabsawy, MD, Rajiv Jalan, PhD Seminars in Nephrology 39 (Issue 1), 17 - 30, 2019 | 114 | 2019 |
Acute-on-chronic liver failure: definition, prognosis and management A Amin, RP Mookerjee Frontline gastroenterology 11 (6), 458-467, 2020 | 23 | 2020 |
Acute liver failure: updates in pathogenesis and management AA Amin, B Agarwal, R Jalan Medicine 47 (12), 838-842, 2019 | 8 | 2019 |
A novel smartphone scleral‐image based tool for assessing jaundice in decompensated cirrhosis patients K Kazankov, M Nixon‐Hill, R Kumar, A Amin, E Alabsawy, A Chikhlia, ... Journal of Gastroenterology and Hepatology 38 (2), 330-336, 2023 | 3 | 2023 |
A novel, smartphone-based scleral image capture technique accurately determines serum bilirubin level and can be used for home-based monitoring of patients discharged from … RM Rahul Kumar, Miranda Nixon, Eman Ibrahim Alabsawy, Ahmed Adel Amin, Felix ... Journal of Hepatology 73 (Supplement 1), S755, 2020 | 1 | 2020 |
Safety and Tolerability of Two Doses of Simvastatin Associated with Rifaximin in Patients with Decompensated Cirrhosis. a Double-Blind, Randomized, Placebo-Controlled Trial P Elisa, L Napoleone, A Amin, D Campion, C Jimenez, S Piano, O Roux, ... HEPATOLOGY 68, 176A-176A, 2018 | | 2018 |
Safety and Tolerability of Two Doses of Simvastatin Associated with Rifaximin in Patients with Decompensated Cirrhosis. A Double-Blind, Randomized, Placebo Controlled Trial. TFGP Pose E, Napoleone L, Amin AA, Campion D, Jimenez C, Piano S, Roux O ... Hepatology 68 (1), abstract 287, 68:176, 2018 | | 2018 |